Case Reports in Medicine

Case Reports in Medicine / 2014 / Article

Case Report | Open Access

Volume 2014 |Article ID 609187 | 4 pages | https://doi.org/10.1155/2014/609187

Postpartum Ovarian Vein and Inferior Vena Cava Thrombosis

Academic Editor: Hitoshi Okamura
Received08 Jan 2014
Revised07 Jun 2014
Accepted09 Jun 2014
Published10 Jul 2014

Abstract

Postpartum ovarian vein thrombosis (POVT), which generally occurs 2–15 days postpartum, is a rare complication. It can be confused with acute appendicitis, pelvic infection, ovarian torsion, tubo-ovarian abscess, and pyelonephritis. It is associated with morbidity and mortality. Here, we present a patient with postpartum OVT and IVC diagnosed by US and CT findings. She was treated successfully with no further need for any interventional procedures.

1. Background

Ovarian vein thrombosis (OVT), which generally occurs between 2 and 15 days postpartum, is a rare complication. OVT occurs in right ovarian vein in almost 90% of patients. It can easily be confused with acute appendicitis, pelvic infection, ovarian torsion, tubo-ovarian abscess, and pyelonephritis. It may lead to fatal complications such as sepsis, inferior vena cava thrombosis (IVC), pulmonary emboli, and death [13].

Before the emergence of radiological imaging modalities, it was quite difficult to diagnose. Most of the definite diagnoses were made during the surgical interventions. But today, the features of this phenomenon are well defined by ultrasonography (US) and computerized tomography (CT). US and CT imaging are reliable and sensitive for the diagnosis of OVT [4, 5]. Here, we present a patient with postpartum OVT and IVC diagnosed by US and CT findings. She was treated successfully with no further need for any interventional procedures.

2. Case Presentation

A 26-year-old puerperal woman was admitted to emergency room with the complaints of severe right lower abdominal pain on the seventh day of an elective cesarean section. She had three children. Her medical and family history revealed no previous history of any thrombotic events. Her pregnancy, labor, and delivery were uneventful. Estimated blood loss during the cesarean section was 1000 cc. Prophylactic low-molecular weight heparin was not given during the postpartum period. Physical examination revealed fever of 39°C and tenderness in her right lower abdominal region. She had mild vaginal discharge.

3. Investigations

Complete blood count and other laboratory tests were as follows: leukocyte count, 15100/μL, Hb 10.4 g/dL; MCV, 72 fL; platelets 592000/μL; CRP, 3.78 mg/dL (reference range 0–0.8 mg/dL); D-Dimer, 2.571 mg/L (reference range: 0–0.5); serum creatinine 0.8 mg/dL. Urinary analysis was otherwise normal. Her body mass index was 24.2.

Diagnosis of renal vein thrombosis was made due to hypoechoic areas in the right renal vein area suggesting thrombosis at first sight. However, the clinical probability of renal vein thrombosis in this woman was low. Because creatinine level was in normal ranges and she did not have hematuria, US and CT imaging were performed. There were hypoechoic areas causing filling defects within the right ovarian vein and inferior vena cava; right ovarian vein was enlarged; and perivascular edema was evident (Figures 1, 2(a), 2(b), and 3).

Laboratory investigations including protein C, protein S, antithrombin III, screening for factor Leiden V and prothrombin G20210A mutations, skin pathergy test, lupus anticoagulant, anticardiolipin antibodies, antinuclear antibody, and antidouble stranded DNA were all negative. Postpartum period was the most possible predisposing factor for the thrombosis in this woman.

4. Differential Diagnosis

Acute appendicitis, tubo-ovarian abscess, or endometritis was included into the differential diagnosis.

5. Treatment

Enoxaparin 6000 U, twice daily, and ampicillin/sulbactam 2 g, q6h, were commenced. Since there was no obvious risk factor other than puerperium, she was advised to use anticoagulation for at least 6 months.

6. Outcome and Follow-Up

She was discharged with no complaints within a week. She received enoxaparin for 6 months and is now on follow-up free from anticoagulation with no recurrence at the 12th month of OVT (Figure 4).

7. Discussion

OVT complicates 1 : 500 to 1 : 2000 deliveries. In a prospective study, the incidence of OVT was 0.02% for vaginal deliveries and 0.1% for cesarean deliveries. The risk of twin versus single delivery and for cesarean section versus vaginal delivery was much higher [1].

Pregnancy-related hypercoagulability is probably the most important risk factor. Protein S and fibrinolytic activity decreases; and factors V, VII, VIII, IX, and X, platelet count, and fibrinogen increase during the postpartum period [4]. Blood flow is retrograde in left and anterograde in right ovarian vein. The physiological dextrorotation of uterus compresses on the right ovarian vein. Venous stasis develops and ovarian vein diameter nearly triples its normal size. The right ovarian vein is longer than the left one. Later also the risk of thrombosis on the right side increases [4, 6, 7]. Hypercoagulable states, such as protein S deficiency and factor Leiden V mutation, surgery, cancer and pelvic inflammatory disease, were implicated as the possible predisposing factors for OVT [8, 9]. Idiopathic OVT is rare and only limited to single case reports [10].

Clinical symptoms are not unique to OVT. Most of the patients with OVT have fever, right lower abdominal or flank pain, subtle back pain, and tenderness in groin and thigh regions. Sometimes a tender lower abdominal mass can be palpated in 50–67% of the patients. Signs and symptoms may be suggestive for acute appendicitis, urinary tract infection, pyelonephritis, adnexal torsion, puerperal endometritis, and tubo-ovarian abscess. These conditions should be included into differential diagnosis [10]. Uterine infection coexists in most of the patients either with or before the symptoms of OVT.

Ultrasound shows hypoechoic/anechoic tubular lesion in upper adnexal and inferior vena cava region. Doppler US can visualize the absence of blood flow and increased ovarian vein diameter. However, peripartum bowel and abdomen gases can reduce the imaging quality. Vascular system can be visualized better and more reliable by contrast enhanced CT and magnetic resonance imaging (MRI). CT’s sensitivity and specificity are around 78%–100% and 63%–99%, respectively, in OVT. CT reveals enlarged ovarian vein, low-density appearance of venous lumen, a sharp vein wall, and perivascular edema. Thrombus in ovarian vein can extend to IVC (15%) or renal vein (12%) [1114]. Under circumstances in which the definite diagnosis cannot be made with those modalities, it is wise to perform a diagnostic laparoscopy.

There are no specific treatment strategies implicated in the treatment of OVT. But, short-term treatment with broad-spectrum antibiotics and 3–6-month administration of parenteral/oral anticoagulants are advised [1].

The recurrence rates are comparable to that of deep vein thrombosis (~3 patient-years). Pulmonary embolism can be observed. The mortality rate was reported to be 4% in a patient series [7].

In this case report, we described a woman who experienced right OVT during the postpartum period. She presented with subtle complaints, such as fever and lower quadrant tenderness. No predisposing factors could be documented other than puerperium. She was successfully treated with one week of broad-spectrum antibiotics and low molecular weight heparin for six months. Clinicians’ awareness, here, helped us for early diagnosis and successful management of a rare disease.

In conclusion, ovarian vein thrombosis is rare. It may be associated with morbidity and mortality. Early diagnosis is crucial to prevent unnecessary interventional procedures, morbidity, and mortality. OVT should be considered in differential diagnosis of a postpartum patient with the complaints of abdominal pain, fever, and leukocytosis.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

References

  1. X. Ortín Font, A. Ugarriza, R. M. Espax et al., “Postpartum ovarian vein thrombosis,” Thrombosis and Haemostasis, vol. 93, no. 5, pp. 1004–1005, 2005. View at: Google Scholar
  2. D. R. Dunnihoo, J. W. Gallaspy, R. B. Wise, and W. N. Otterson, “Postpartum ovarian vein thrombophlebitis: a review,” Obstetrical and Gynecological Survey, vol. 46, no. 7, pp. 415–427, 1991. View at: Publisher Site | Google Scholar
  3. D. Sinha, H. Yasmin, and J. S. Samra, “Postpartum inferior vena cava and ovarian vein thrombosis—a case report and literature review,” Journal of Obstetrics and Gynaecology, vol. 25, no. 3, pp. 312–313, 2005. View at: Publisher Site | Google Scholar
  4. C. J. Calderwood, R. Jamieson, and I. A. Greer, “Gestational related changes in the deep venous system of the lower limb on light reflection rheography in pregnancy and the puerperium,” Clinical Radiology, vol. 62, no. 12, pp. 1174–1179, 2007. View at: Publisher Site | Google Scholar
  5. L. K. Quane, D. D. Kidney, and A. J. Cohen, “Unusual causes of ovarian vein thrombosis as revealed by CT and sonography,” American Journal of Roentgenology, vol. 171, no. 2, pp. 487–490, 1998. View at: Publisher Site | Google Scholar
  6. S. J. Savader, R. R. Otero, and B. L. Savader, “Puerperal ovarian vein thrombosis: Evaluation with CT, US, and MR imaging,” Radiology, vol. 167, no. 3, pp. 637–639, 1988. View at: Google Scholar
  7. O. Salomon, M. Dulitzky, and S. Apter, “New observations in postpartum ovarian vein thrombosis: experience of single center,” Blood Coagulation and Fibrinolysis, vol. 21, no. 1, pp. 16–19, 2010. View at: Publisher Site | Google Scholar
  8. M. S. Gakhal, H. M. Levy, M. Spina, and C. Wrigley, “Ovarian vein thrombosis: analysis of patient age, etiology, and side of involvement.,” Delaware Medical Journal, vol. 85, no. 2, pp. 45–59, 2013. View at: Google Scholar
  9. S. Guler, O. F. Kokoglu, H. Ucmak, and F. Özkan, “Postpartum ovarian vein thrombosis and renal vein thrombosis in a woman with protein S and C deficiency,” BMJ Case Reports, 2013. View at: Publisher Site | Google Scholar
  10. A. Johnson, E. D. Wietfeldt, V. Dhevan, and I. Hassan, “Right lower quadrant pain and postpartum ovarian vein thrombosis. Uncommon but not forgotten,” Archives of Gynecology and Obstetrics, vol. 281, no. 2, pp. 261–263, 2010. View at: Publisher Site | Google Scholar
  11. E. M. Wysokinska, D. Hodge, and R. D. McBane II, “Ovarian vein thrombosis: Incidence of recurrent venous thromboembolism and survival,” Thrombosis and Haemostasis, vol. 96, no. 2, pp. 126–131, 2006. View at: Publisher Site | Google Scholar
  12. D. M. Mwickier, A. T. Setiawan, R. S. Evans et al., “Imaging of puerperal septic thrombophlebitis: prospective comparison of MR imaging, CT, and sonography,” American Journal of Roentgenology, vol. 169, no. 4, pp. 1039–1043, 1997. View at: Publisher Site | Google Scholar
  13. A. Själander, J.-H. Jansson, D. Bergqvist, H. Eriksson, B. Carlberg, and P. Svensson, “Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis,” Journal of Internal Medicine, vol. 263, no. 1, pp. 52–60, 2008. View at: Publisher Site | Google Scholar
  14. A. Al-toma, B. G. F. Heggelman, and M. H. H. Kramer, “Postpartum ovarian vein thrombosis: report of a case and review of literature,” Netherlands Journal of Medicine, vol. 61, no. 10, pp. 334–336, 2003. View at: Google Scholar

Copyright © 2014 Harun Arslan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1479 Views | 430 Downloads | 5 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.